Abiomed Stock Net Income
ABIOMED fundamentals help investors to digest information that contributes to ABIOMED's financial success or failures. It also enables traders to predict the movement of ABIOMED Stock. The fundamental analysis module provides a way to measure ABIOMED's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ABIOMED stock.
ABIOMED |
ABIOMED Company Net Income Analysis
ABIOMED's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current ABIOMED Net Income | 136.5 M |
Most of ABIOMED's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ABIOMED is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, ABIOMED reported net income of 136.5 M. This is 60.0% lower than that of the Health Care Equipment & Supplies sector and 42.67% lower than that of the Health Care industry. The net income for all United States stocks is 76.09% higher than that of the company.
ABIOMED Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ABIOMED's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ABIOMED could also be used in its relative valuation, which is a method of valuing ABIOMED by comparing valuation metrics of similar companies.ABIOMED is currently under evaluation in net income category among its peers.
ABIOMED Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0955 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 16.32 B | |||
| Shares Outstanding | 45.09 M | |||
| Shares Owned By Insiders | 2.02 % | |||
| Shares Owned By Institutions | 97.00 % | |||
| Number Of Shares Shorted | 753.62 K | |||
| Price To Earning | 76.38 X | |||
| Price To Book | 11.13 X | |||
| Price To Sales | 15.96 X | |||
| Revenue | 1.03 B | |||
| Gross Profit | 843.6 M | |||
| EBITDA | 268.49 M | |||
| Net Income | 136.5 M | |||
| Cash And Equivalents | 844.32 M | |||
| Cash Per Share | 18.57 X | |||
| Total Debt | 10 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 7.53 X | |||
| Book Value Per Share | 34.09 X | |||
| Cash Flow From Operations | 285.39 M | |||
| Short Ratio | 0.39 X | |||
| Earnings Per Share | 5.83 X | |||
| Price To Earnings To Growth | 2.75 X | |||
| Target Price | 363.0 | |||
| Number Of Employees | 2 K | |||
| Beta | 1.4 | |||
| Market Capitalization | 17.18 B | |||
| Total Asset | 1.67 B | |||
| Retained Earnings | 650.05 M | |||
| Working Capital | 241.85 M | |||
| Current Asset | 288.39 M | |||
| Current Liabilities | 46.54 M | |||
| Net Asset | 1.67 B |
About ABIOMED Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ABIOMED's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABIOMED using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABIOMED based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |